Advanced glycation endproducts in food and their effects on health.
暂无分享,去创建一个
L. Skibsted | L. Dragsted | B. de Courten | R. V. Hedegaard | S. Bügel | J. Nielsen | Malene W Poulsen | Jeanette M. Andersen
[1] Ye Xu,et al. Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease. , 2013, Antioxidants & redox signaling.
[2] A. Katz. Noncommunicable Diseases: Global Health Priority or Market Opportunity? An Illustration of the World Health Organization at its Worst and at its Best , 2013, International journal of health services : planning, administration, evaluation.
[3] V. Gökmen,et al. Antiglycative effect of fruit and vegetable seed extracts: inhibition of AGE formation and carbonyl-trapping abilities. , 2013, Journal of the science of food and agriculture.
[4] N. Kellow,et al. Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review , 2013, European Journal of Clinical Nutrition.
[5] L. Nikitina-Zake,et al. Identification of glyoxalase 1 polymorphisms associated with enzyme activity. , 2013, Gene.
[6] M. Cooper,et al. Targeting the AGE‐RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end‐product content , 2013, Nephrology.
[7] Adam J Rosenberg,et al. Total synthesis of pentosidine. , 2012, Organic letters.
[8] G. Striker,et al. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1 , 2012, Proceedings of the National Academy of Sciences.
[9] M. Hellwig,et al. 1,2-dicarbonyl compounds in commonly consumed foods. , 2012, Journal of agricultural and food chemistry.
[10] Zhongling Zhang,et al. Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective , 2012, Journal of the Neurological Sciences.
[11] Rendy Kartika,et al. Exploring post-translational arginine modification using chemically synthesized methylglyoxal hydroimidazolones. , 2012, Journal of the American Chemical Society.
[12] R. Fernandes,et al. Methylglyoxal promotes oxidative stress and endothelial dysfunction. , 2012, Pharmacological research.
[13] Paul J Thornalley,et al. Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation. , 2012, The Biochemical journal.
[14] Paul J Thornalley,et al. Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome , 2012, Amino Acids.
[15] L. Dragsted,et al. Convenient Synthesis of Nε-(Carboxymethyl)lysine,a Key Advanced Glycation Endproduct Biomarker , 2012 .
[16] J. Woodside,et al. Nε-(carboxymethyl)lysine content of foods commonly consumed in a Western style diet , 2012 .
[17] T. Imaizumi,et al. Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects. , 2012, Cardiovascular therapeutics.
[18] D. Maślińska,et al. Immunodistribution of amyloid beta protein (Aβ) and advanced glycation end-product receptors (RAGE) in choroid plexus and ependyma of resuscitated patients. , 2011, Folia neuropathologica.
[19] R. Ramasamy,et al. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications , 2011, Annals of the New York Academy of Sciences.
[20] K. Clément,et al. Dietary factors and low-grade inflammation in relation to overweight and obesity , 2011, British Journal of Nutrition.
[21] Gong Zhang,et al. Determination of advanced glycation endproducts by LC-MS/MS in raw and roasted almonds (Prunus dulcis). , 2011, Journal of agricultural and food chemistry.
[22] I. Seiquer,et al. Study of the urinary and faecal excretion of Nε-carboxymethyllysine in young human volunteers , 2011, Amino Acids.
[23] H. Qian,et al. Melanoidins produced by the Maillard reaction: Structure and biological activity , 2011 .
[24] M. Knip,et al. Advanced Glycation End Products Are Direct Modulators of β-Cell Function , 2011, Diabetes.
[25] L. Ferrucci,et al. Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults. , 2011, The Journal of nutrition.
[26] S. Manna,et al. Advanced Glycation End Products (AGEs) Induce Apoptosis via a Novel Pathway , 2011, The Journal of Biological Chemistry.
[27] M. T. Luu,et al. Glycation induction and antiglycation activity of skin care ingredients on living human skin explants , 2011, International journal of cosmetic science.
[28] M. Sakaguchi,et al. TIRAP, an Adaptor Protein for TLR2/4, Transduces a Signal from RAGE Phosphorylated upon Ligand Binding , 2011, PloS one.
[29] J. Tang,et al. Association of two glyoxalase I gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes , 2011, Journal of endocrinological investigation.
[30] Merlin C. Thomas,et al. Targeted reduction of advanced glycation improves renal function in obesity. , 2011, Kidney international.
[31] Gretchen A. Stevens,et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.
[32] K. Tan,et al. Serum advanced glycation end products (AGEs) are associated with insulin resistance , 2011, Diabetes/metabolism research and reviews.
[33] G. Striker,et al. Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes , 2011, Diabetes Care.
[34] Y. Lee,et al. Preventive effect of chlorogenic acid on lens opacity and cytotoxicity in human lens epithelial cells. , 2011, Biological & pharmaceutical bulletin.
[35] G. Yen,et al. Inhibition of advanced glycation endproduct formation by foodstuffs. , 2011, Food & function.
[36] G. Striker,et al. AGE restriction in diabetes mellitus: a paradigm shift , 2011, Nature Reviews Endocrinology.
[37] M. Hellwig,et al. Transport of Free and Peptide‐Bound Glycated Amino Acids: Synthesis, Transepithelial Flux at Caco‐2 Cell Monolayers, and Interaction with Apical Membrane Transport Proteins , 2011, Chembiochem : a European journal of chemical biology.
[38] Y. Lee,et al. Chlorogenic acid inhibits the formation of advanced glycation end products and associated protein cross-linking , 2011, Archives of pharmacal research.
[39] A. Lampen,et al. Toxicology and risk assessment of 5-Hydroxymethylfurfural in food. , 2011, Molecular nutrition & food research.
[40] P. Jiang,et al. Advanced glycation end-products induce heparanase expression in endothelial cells by the receptor for advanced glycation end products and through activation of the FOXO4 transcription factor , 2011, Molecular and Cellular Biochemistry.
[41] Yong-de Peng,et al. Glyoxalase I and aldose reductase gene polymorphisms and susceptibility to carotid atherosclerosis in type 2 diabetes. , 2011, Genetic testing and molecular biomarkers.
[42] V. Tesar,et al. Associations of Serum Levels of Advanced Glycation end Products with Nutrition Markers and Anemia in Patients with Chronic Kidney Disease , 2011, Renal failure.
[43] C. Heizmann,et al. Glycolaldehyde-modified β-lactoglobulin AGEs are unable to stimulate inflammatory signaling pathways in RAGE-expressing human cell lines. , 2011, Molecular nutrition & food research.
[44] I. Mook‐Jung,et al. RAGE: The beneficial and deleterious effects by diverse mechanisms of actions , 2011, Molecules and cells.
[45] M. Glomb,et al. Formation of arginine modifications in a model system of Nα-tert-butoxycarbonyl (Boc)-arginine with methylglyoxal. , 2011, Journal of agricultural and food chemistry.
[46] I. Birlouez-Aragon,et al. Health effects of dietary Maillard reaction products: the results of ICARE and other studies , 2010, Amino Acids.
[47] V. Fogliano,et al. Physiological relevance of dietary melanoidins , 2010, Amino Acids.
[48] R. Morawicki,et al. Enzymatic hydrolysis of poultry meal with endo- and exopeptidases. , 2010, Poultry science.
[49] M. Hellwig,et al. 3-deoxygalactosone, a "new" 1,2-dicarbonyl compound in milk products. , 2010, Journal of agricultural and food chemistry.
[50] Masayoshi Takeuchi,et al. Pyridoxamine, an inhibitor of advanced glycation end product (AGE) formation ameliorates insulin resistance in obese, type 2 diabetic mice. , 2010, Protein and peptide letters.
[51] Merlin C. Thomas,et al. Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy. , 2010, Kidney international.
[52] G. Striker,et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. , 2010, Journal of the American Dietetic Association.
[53] R. Ramasamy,et al. Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. , 2010, Biochemical pharmacology.
[54] G. Cravotto,et al. Microwave-assisted Maillard reactions for the preparation of advanced glycation end products (AGEs). , 2010, Organic & biomolecular chemistry.
[55] T. Outeiro,et al. The sour side of neurodegenerative disorders: the effects of protein glycation , 2010, The Journal of pathology.
[56] J. Lecerf,et al. A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. , 2010, The American journal of clinical nutrition.
[57] L. Sayre,et al. A straightforward synthesis of pentosidine framework , 2010 .
[58] V. Fogliano,et al. Lipid oxidation promotes acrylamide formation in fat-rich model systems , 2010 .
[59] Chien-Ning Huang,et al. Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1α and MCP-1 levels in type 2 diabetic patients , 2010, European journal of nutrition.
[60] Merlin C. Thomas,et al. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. , 2010, American journal of physiology. Renal physiology.
[61] D. Cervantes-Laurean,et al. Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products. , 2010, Free radical biology & medicine.
[62] G. Striker,et al. AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease. , 2010, American journal of physiology. Cell physiology.
[63] M. Hellwig,et al. Transport of the advanced glycation end products alanylpyrraline and pyrralylalanine by the human proton-coupled peptide transporter hPEPT1. , 2010, Journal of agricultural and food chemistry.
[64] I. Seiquer,et al. Intake of Maillard reaction products reduces iron bioavailability in male adolescents. , 2009, Molecular nutrition & food research.
[65] Tsukasa Suzuki,et al. Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients. , 2009, Metabolism: clinical and experimental.
[66] L. Ferrucci,et al. Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. , 2009, The Journal of clinical endocrinology and metabolism.
[67] M. Beckmann,et al. A diet rich in Maillard reaction products protects LDL against copper induced oxidation ex vivo, a human intervention trial , 2009 .
[68] E. Marceau,et al. Profiling of alpha-dicarbonyl content of commercial honeys from different botanical origins: identification of 3,4-dideoxyglucoson-3-ene (3,4-DGE) and related compounds. , 2009, Journal of agricultural and food chemistry.
[69] Kentaro Tsuji-Naito,et al. Inhibitory effects of Chrysanthemum species extracts on formation of advanced glycation end products , 2009 .
[70] G. Striker,et al. Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia. , 2009, The American journal of pathology.
[71] S. Ito,et al. Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague–Dawley rats , 2009, Journal of hypertension.
[72] A. Heidland,et al. Plasma advanced glycation end products are decreased in obese children compared with lean controls. , 2009, International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity.
[73] Daisuke Koya,et al. SIRT1 and insulin resistance , 2009, Nature Reviews Endocrinology.
[74] M. Hellwig,et al. Transport of free and peptide-bound pyrraline at intestinal and renal epithelial cells. , 2009, Journal of agricultural and food chemistry.
[75] D. Ströhl,et al. A Robust Synthesis of Nε-(Carboxymethyl)-L-lysine (CML) , 2009 .
[76] T. Delatour,et al. Analysis of advanced glycation endproducts in dairy products by isotope dilution liquid chromatography-electrospray tandem mass spectrometry. The particular case of carboxymethyllysine. , 2009, Journal of chromatography. A.
[77] Qibin Zhang,et al. A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. , 2009, Journal of proteome research.
[78] S. Yamagishi,et al. Effects of high-AGE beverage on RAGE and VEGF expressions in the liver and kidneys , 2009, European journal of nutrition.
[79] J. Ames,et al. Determination of Nɛ-(carboxymethyl)lysine in food systems by ultra performance liquid chromatography-mass spectrometry , 2009, Amino Acids.
[80] R. Hoffmann,et al. Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)* , 2008, Journal of Biological Chemistry.
[81] J. Ames. Mass spectrometry to detect the site specificity of advanced glycation/lipoxidation end-product formation on protein: some challenges and solutions. , 2008, Biochemical Society transactions.
[82] T. Koschinsky,et al. Leptin decreases postprandially in people with type 2 diabetes, an effect reduced by the cooking method. , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[83] Merlin C. Thomas,et al. Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes , 2008, Diabetes.
[84] Merlin C. Thomas,et al. Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. , 2008, American journal of physiology. Endocrinology and metabolism.
[85] G. Striker,et al. Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. , 2008, The American journal of pathology.
[86] T. Henle. Maillard Reaction of Proteins and Advanced Glycation End Products (AGEs) in Food , 2008 .
[87] Su-Yen Goh,et al. The role of advanced glycation end products in progression and complications of diabetes , 2008 .
[88] K. Herold,et al. Receptor for Advanced Glycation End Products , 2008, Annals of the New York Academy of Sciences.
[89] J. Ames. Determination ofNɛ‐(Carboxymethyl)lysine in Foods and Related Systems , 2008, Annals of the New York Academy of Sciences.
[90] T. Koschinsky,et al. Dietary Advanced Glycation Endproducts and Oxidative Stress , 2008, Annals of the New York Academy of Sciences.
[91] J. Lecerf,et al. Strategy for the Study of the Health Impact of Dietary Maillard Products in Clinical Studies , 2008, Annals of the New York Academy of Sciences.
[92] Chi-Tang Ho,et al. Reactive dicarbonyl compounds and 5-(hydroxymethyl)-2-furfural in carbonated beverages containing high fructose corn syrup , 2008 .
[93] C. Heizmann,et al. N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response. , 2008, Molecular nutrition & food research.
[94] T. Imaizumi,et al. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein‐1 (MCP‐1) levels in patients with type 2 diabetes , 2008, Diabetes/metabolism research and reviews.
[95] M. Nakhjavani,et al. Effect of spermine on lipid profile and HDL functionality in the streptozotocin-induced diabetic rat model. , 2008, Life sciences.
[96] R. Ramasamy,et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. , 2008, The Journal of clinical investigation.
[97] W. R. Bruce,et al. Marginal thiamine deficiency increases oxidative markers in the plasma and selected tissues in F344 rats , 2007 .
[98] Mark E. Williams,et al. Effects of Pyridoxamine in Combined Phase 2 Studies of Patients with Type 1 and Type 2 Diabetes and Overt Nephropathy , 2007, American Journal of Nephrology.
[99] J. Ames. Evidence against dietary advanced glycation endproducts being a risk to human health. , 2007, Molecular nutrition & food research.
[100] T. Henle. Dietary advanced glycation end products--a risk to human health? A call for an interdisciplinary debate. , 2007, Molecular nutrition & food research.
[101] K. Šebeková,et al. Dietary advanced glycation endproducts (AGEs) and their health effects--PRO. , 2007, Molecular nutrition & food research.
[102] R. Ramasamy,et al. Arguing for the motion: yes, RAGE is a receptor for advanced glycation endproducts. , 2007, Molecular nutrition & food research.
[103] Paul J Thornalley. Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE)--an introduction. , 2007, Molecular nutrition & food research.
[104] C. Heizmann. The mechanism by which dietary AGEs are a risk to human health is via their interaction with RAGE: arguing against the motion. , 2007, Molecular nutrition & food research.
[105] V. Gökmen,et al. Effects of some cations on the formation of acrylamide and furfurals in glucose–asparagine model system , 2007 .
[106] B. Stratmann,et al. Adiponectin Decreases Postprandially Following a Heat-Processed Meal in Individuals With Type 2 Diabetes , 2007, Diabetes Care.
[107] G. Striker,et al. Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. , 2007, The American journal of pathology.
[108] M. Laakso,et al. Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study , 2007, Diabetologia.
[109] F. Hou,et al. Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model. , 2007, Kidney international.
[110] Bernd Stratmann,et al. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. , 2007, The American journal of clinical nutrition.
[111] Manuel Dornier,et al. Thermal degradation of antioxidant micronutrients in citrus juice: kinetics and newly formed compounds. , 2007, Journal of agricultural and food chemistry.
[112] L. Ferrucci,et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.
[113] V. Somoza,et al. Forty years of furosine - forty years of using Maillard reaction products as indicators of the nutritional quality of foods. , 2007, Molecular nutrition & food research.
[114] I. Seiquer,et al. Maillard reaction indicators in diets usually consumed by adolescent population. , 2007, Molecular nutrition & food research.
[115] I. Birlouez-Aragon,et al. Evaluation of a gas chromatography/mass spectrometry method for the quantification of carboxymethyllysine in food samples. , 2007, Journal of chromatography. A.
[116] Parvez Hossain,et al. Obesity and diabetes in the developing world--a growing challenge. , 2007, The New England journal of medicine.
[117] C. Nguyen. Toxicity of the AGEs generated from the Maillard reaction: On the relationship of food‐AGEs and biological‐AGEs , 2006 .
[118] C. Murray,et al. Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment , 2006, The Lancet.
[119] Jens Pietzsch,et al. Biodistribution and catabolism of 18F-labeled N-ε-fructoselysine as a model of Amadori products , 2006 .
[120] L. Hunsicker,et al. The Advanced Glycation End Product Nε-Carboxymethyllysine Is Not a Predictor of Cardiovascular Events and Renal Outcomes in Patients With Type 2 Diabetic Kidney Disease and Hypertension , 2006 .
[121] J. He,et al. Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor , 2006, Proceedings of the National Academy of Sciences.
[122] V. Somoza,et al. Dose-dependent utilisation of casein-linked lysinoalanine, N(epsilon)-fructoselysine and N(epsilon)-carboxymethyllysine in rats. , 2006, Molecular nutrition & food research.
[123] M. Murkovic,et al. Analysis of 5-hydroxymethylfurfual in coffee, dried fruits and urine. , 2006, Molecular nutrition & food research.
[124] J. Silvan,et al. Analysis and biological properties of amino acid derivates formed by Maillard reaction in foods. , 2006, Journal of pharmaceutical and biomedical analysis.
[125] Michael J. Pencina,et al. Trends in the Incidence of Type 2 Diabetes Mellitus From the 1970s to the 1990s: The Framingham Heart Study , 2006, Circulation.
[126] M. Brandsch,et al. Transepithelial flux of early and advanced glycation compounds across Caco-2 cell monolayers and their interaction with intestinal amino acid and peptide transport systems. , 2006, The British journal of nutrition.
[127] I. Seiquer,et al. Diets rich in Maillard reaction products affect protein digestibility in adolescent males aged 11-14 y. , 2006, The American journal of clinical nutrition.
[128] J. Schneider,et al. Postprandial mononuclear NF-kappaB activation is independent of the AGE-content of a single meal. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[129] M. Zeier,et al. An oral load of the early glycation compound lactuloselysine fails to accumulate in the serum of uraemic patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[130] F. Fenaille,et al. Synthesis, tandem MS- and NMR-based characterization, and quantification of the carbon 13-labeled advanced glycation endproduct, 6-N-carboxymethyllysine , 2006, Amino Acids.
[131] M. Engelse,et al. Interaction of Nepsilon(carboxymethyl)lysine- and methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs. , 2006, Thrombosis and haemostasis.
[132] Paul J Thornalley. Measurement of Protein Glycation, Glycated Peptides, and Glycation Free Adducts , 2005, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[133] W. R. Bruce,et al. The effects of partial thiamin deficiency and oxidative stress (i.e., glyoxal and methylglyoxal) on the levels of α‐oxoaldehyde plasma protein adducts in Fischer 344 rats , 2005, FEBS letters.
[134] P. Gruber,et al. Chemoselective synthesis of peptides containing major advanced glycation end-products of lysine and arginine. , 2005, The journal of peptide research : official journal of the American Peptide Society.
[135] J. Uribarri,et al. Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. , 2005, Diabetes.
[136] T. Henle. Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods , 2005, Amino Acids.
[137] Veronika Somoza,et al. Five years of research on health risks and benefits of Maillard reaction products: an update. , 2005, Molecular nutrition & food research.
[138] Paul J Thornalley,et al. Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection. , 2005, Molecular nutrition & food research.
[139] M. N. Ramesh,et al. Thermal degradation kinetics of nutrients in orange juice heated by electromagnetic and conventional methods , 2005 .
[140] Volker Böhm,et al. Processing strawberries to different products alters contents of vitamin C, total phenolics, total anthocyanins, and antioxidant capacity. , 2005, Journal of agricultural and food chemistry.
[141] A. Heidland,et al. Dietary Bread Crust Advanced Glycation End Products Bind to the Receptor for AGEs in HEK‐293 Kidney Cells but Are Rapidly Excreted after Oral Administration to Healthy and Subtotally Nephrectomized Rats , 2005, Annals of the New York Academy of Sciences.
[142] T. Henle,et al. Studies on Absorption and Elimination of Dietary Maillard Reaction Products , 2005, Annals of the New York Academy of Sciences.
[143] J. Uribarri,et al. Diet‐Derived Advanced Glycation End Products Are Major Contributors to the Body's AGE Pool and Induce Inflammation in Healthy Subjects , 2005, Annals of the New York Academy of Sciences.
[144] A. Smit,et al. Simple Noninvasive Measurement of Skin Autofluorescence , 2005, Annals of the New York Academy of Sciences.
[145] V. Yaylayan,et al. Oxidative Pyrolysis and Postpyrolytic Derivatization Techniques for the Total Analysis of Maillard Model Systems: Investigation of Control Parameters of Maillard Reaction Pathways , 2005, Annals of the New York Academy of Sciences.
[146] F. Hidalgo,et al. Interplay between the Maillard Reaction and Lipid Peroxidation in Biochemical Systems , 2005, Annals of the New York Academy of Sciences.
[147] P. Boor,et al. Renal Effects of Oral Maillard Reaction Product Load in the Form of Bread Crusts in Healthy and Subtotally Nephrectomized Rats , 2005, Annals of the New York Academy of Sciences.
[148] P. Beisswenger,et al. Ketosis Leads to Increased Methylglyoxal Production on the Atkins Diet , 2005, Annals of the New York Academy of Sciences.
[149] N. V. Chuyen,et al. Are Food Advanced Glycation End Products Toxic in Biological Systems? , 2005, Annals of the New York Academy of Sciences.
[150] H. Nursten. The Maillard Reaction: Chemistry, Biochemistry and Implications , 2005 .
[151] B. Hudson,et al. Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage , 2005, Cellular and Molecular Life Sciences CMLS.
[152] P. Finot. The absorption and metabolism of modified amino acids in processed foods. , 2005, Journal of AOAC International.
[153] J. Hwang,et al. Clinical implications of Nε‐(carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes , 2005, Diabetes, obesity & metabolism.
[154] M. Laakso,et al. High Serum Levels of Advanced Glycation End Products Predict Increased Coronary Heart Disease Mortality in Nondiabetic Women but not in Nondiabetic Men: A Population-Based 18-Year Follow-Up Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[155] Neil Mann,et al. Origins and evolution of the Western diet: health implications for the 21st century. , 2005, The American journal of clinical nutrition.
[156] C. Cordeiro,et al. Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy. , 2005, The Biochemical journal.
[157] F. Hidalgo,et al. Coordinate Contribution of Lipid Oxidation and Maillard Reaction to the Nonenzymatic Food Browning , 2005, Critical reviews in food science and nutrition.
[158] S. Horiuchi,et al. Conventional antibody against Nε-(carboxymethyl)lysine (CML) shows cross-reaction to Nε-(carboxyethyl)lysine (CEL): Immunochemical quantification of CML with a specific antibody , 2004 .
[159] A. Smit,et al. The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation. , 2004, Current medicinal chemistry.
[160] J. He,et al. Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[161] J. Uribarri,et al. Advanced glycoxidation end products in commonly consumed foods. , 2004, Journal of the American Dietetic Association.
[162] J. Uribarri,et al. Glycoxidation and Diabetic Complications: Modern Lessons and a Warning? , 2004, Reviews in Endocrine and Metabolic Disorders.
[163] J. Uribarri,et al. High Levels of Dietary Advanced Glycation End Products Transform Low-Dersity Lipoprotein Into a Potent Redox-Sensitive Mitogen-Activated Protein Kinase Stimulant in Diabetic Patients , 2004, Circulation.
[164] U. Ott,et al. Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. , 2004, Kidney international.
[165] J. Rufián‐Henares,et al. Pyrraline content in enteral formula processing and storage and model systems , 2004 .
[166] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[167] D. Kass,et al. Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease. , 2004, Congestive heart failure.
[168] C. Dinarello,et al. Effect of advanced glycation end products on endotoxin-induced TNF-alpha, IL-1beta and IL-8 in human peripheral blood mononuclear cells. , 2004, Clinical nephrology.
[169] T. Hughes,et al. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products , 2004, Diabetologia.
[170] J. Uribarri,et al. Glycoxidation and inflammation in renal failure patients. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[171] A. Tritscher. Human health risk assessment of processing-related compounds in food. , 2004, Toxicology letters.
[172] T. Sugimura,et al. Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish , 2004, Cancer science.
[173] J. Buchert,et al. Industrial Enzymes: Enzymes in Nonfood Applications , 2004 .
[174] M. Peppa,et al. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. , 2003, Diabetes.
[175] Anne Dawnay,et al. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. , 2003, The Biochemical journal.
[176] Paul J Thornalley. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. , 2003, Archives of biochemistry and biophysics.
[177] T. Miyata,et al. Advanced glycation end products in uremia. , 2003, Advances in renal replacement therapy.
[178] J. Uribarri,et al. Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[179] M. Peppa,et al. Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice. , 2003, Diabetes.
[180] E. Fisher,et al. Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice. , 2003, Atherosclerosis.
[181] T. Henle. AGEs in foods: do they play a role in uremia? , 2003, Kidney international. Supplement.
[182] A. Heidland,et al. Effects of a diet rich in advanced glycation end products in the rat remnant kidney model. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[183] J. Uribarri,et al. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. , 2003, Journal of the American Society of Nephrology : JASN.
[184] T. Henle,et al. Studies on the formation of furosine and pyridosine during acid hydrolysis of different Amadori products of lysine , 2003 .
[185] M. Huijberts,et al. N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients. , 2003, Diabetes & metabolism.
[186] G. P. Rizzi. Free Radicals in the Maillard Reaction , 2003 .
[187] T. Hofmann,et al. RAGE-mediated MAPK activation by food-derived AGE and non-AGE products. , 2003, Biochemical and biophysical research communications.
[188] T. Kislinger,et al. RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice , 2002, Circulation.
[189] M. Peppa,et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[190] Monica Anese,et al. Chemical characterization and antioxidant properties of coffee melanoidins. , 2002, Journal of agricultural and food chemistry.
[191] E. Fisher,et al. Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice. , 2002, Atherosclerosis.
[192] Eden Tareke,et al. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. , 2002, Journal of agricultural and food chemistry.
[193] C. Wanner,et al. Advanced glycation end products and mortality in hemodialysis patients. , 2002, Kidney international.
[194] E. Fisher,et al. Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. , 2002, Diabetes.
[195] M. Peppa,et al. Oxidative Stress-Inducing Carbonyl Compounds From Common Foods: Novel Mediators of Cellular Dysfunction , 2002, Molecular medicine.
[196] R. Bucala,et al. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. , 2002, Diabetes care.
[197] Paul J Thornalley,et al. Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin. , 2002, The Biochemical journal.
[198] M. Steffes,et al. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products , 2002, Diabetes/metabolism research and reviews.
[199] Q. Beg,et al. Bacterial alkaline proteases: molecular approaches and industrial applications , 2002, Applied Microbiology and Biotechnology.
[200] H. Erbersdobler,et al. Effect of Heat-Treated Proteins on Selected Parameters of the Biotransformation System in the Rat , 2002, Annals of Nutrition and Metabolism.
[201] P. Schieberle,et al. Chemical interactions between odor-active thiols and melanoidins involved in the aroma staling of coffee beverages. , 2002, Journal of agricultural and food chemistry.
[202] A. Heidland,et al. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related? , 2001, Clinical nephrology.
[203] A. Heidland,et al. Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet , 2001, European journal of nutrition.
[204] R. Günther,et al. RAGE expression and AGE-induced MAP kinase activation in Caco-2 cells. , 2001, Biochemical and biophysical research communications.
[205] M. Glomb,et al. Amides Are Novel Protein Modifications Formed by Physiological Sugars* , 2001, The Journal of Biological Chemistry.
[206] J. Nagy,et al. N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[207] M. Crow,et al. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. , 2001, Diabetes.
[208] H. Erbersdobler,et al. Metabolic transit of Amadori products. , 2001, Die Nahrung.
[209] M. Scheunemann,et al. Radio fluorination and positron emission tomography (PET) as a new approach to study the in vivo distribution and elimination of the advanced glycation endproducts Nε-carboxymethyllysine (CML) and nε-carboxyethyllysine (CEL) , 2001 .
[210] H. Bühler,et al. Identification and quantitative evaluation of the lysine-arginine crosslinks GODIC, MODIC, DODIC, and glucosepan in foods. , 2001, Die Nahrung.
[211] F. Yokokawa,et al. An expeditious synthesis of pentosidine, an advanced glycation end product , 2001 .
[212] A. Schmidt,et al. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. , 2001, American journal of physiology. Endocrinology and metabolism.
[213] P. Schieberle,et al. Model studies on the influence of coffee melanoidins on flavor volatiles of coffee beverages. , 2001, Journal of agricultural and food chemistry.
[214] W. Hung,et al. Role of receptor for advanced glycation end‐product (RAGE) and the JAK/STAT‐signaling pathway in AGE‐induced collagen production in NRK‐49F cells , 2001, Journal of cellular biochemistry.
[215] T. Koschinsky,et al. Presence of Diabetic Complications in Type 1 Diabetic Patients Correlates with Low Expression of Mononuclear Cell AGE-Receptor-1 and Elevated Serum AGE , 2001, Molecular medicine.
[216] H. Erbersdobler,et al. Metabolic Transit and in vivo Effects of Melanoidins and Precursor Compounds Deriving from the Maillard Reaction , 2001, Annals of Nutrition and Metabolism.
[217] A. Schmidt,et al. The biology of the receptor for advanced glycation end products and its ligands. , 2000, Biochimica et biophysica acta.
[218] Alan W. Stitt,et al. Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease. , 2000, Kidney international.
[219] J. Schlatter,et al. 5-Hydroxymethylfurfural: assessment of mutagenicity, DNA-damaging potential and reactivity towards cellular glutathione. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[220] P. Schieberle,et al. Quantitative model studies on the formation of aroma-active aldehydes and acids by strecker-type reactions. , 2000, Journal of agricultural and food chemistry.
[221] Paul J Thornalley,et al. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. , 1999, The Biochemical journal.
[222] R. Klaiber,et al. Cross-linking of proteins by Maillard processes: characterization and detection of lysine-arginine cross-links derived from glyoxal and methylglyoxal. , 1999, Bioorganic & medicinal chemistry.
[223] T. Kislinger,et al. N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression* , 1999, The Journal of Biological Chemistry.
[224] N. Ankrah,et al. Toxicity of low levels of methylglyoxal: depletion of blood glutathione and adverse effect on glucose tolerance in mice. , 1999, Toxicology letters.
[225] K. Birkeland,et al. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. , 1999, Diabetes care.
[226] B. Wedzicha,et al. Nonenzymatic browning reactions of retro-aldol degradation products of carbohydrates , 1999 .
[227] H. Huttunen,et al. Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways* , 1999, The Journal of Biological Chemistry.
[228] H. Vlassara,et al. Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration. , 1999, Diabetes.
[229] S. Drusch,et al. Determination of Nϵ-carboxymethyllysine in milk products by a modified reversed-phase HPLC method , 1999 .
[230] F. Cuccurullo,et al. Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications. , 1999, The Journal of pediatrics.
[231] A. Schmidt,et al. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. , 1999, Circulation research.
[232] T. Florea,et al. Evaluation of radical products from beta-alanine/sugar mixtures by use of GC-MS with the galvinoxyl radical. , 1999, Journal of agricultural and food chemistry.
[233] T. Hofmann,et al. Studies on radical intermediates in the early stage of the nonenzymatic browning reaction of carbohydrates and amino acids. , 1999, Journal of agricultural and food chemistry.
[234] M. Fountoulakis,et al. Hydrolysis and amino acid composition analysis of proteins , 1998 .
[235] Paul J Thornalley. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. , 1998, Cellular and molecular biology.
[236] J. Clausen,et al. The advanced glycation end product Nepsilon-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes. , 1998, Diabetes care.
[237] T. Hofmann. AcetylformoinA Chemical Switch in the Formation of Colored Maillard Reaction Products from Hexoses and Primary and Secondary Amino Acids , 1998 .
[238] T. Hofmann. Studies on the relationship between molecular weight and the color potency of fractions obtained by thermal treatment of glucose/amino acid and glucose/protein solutions by using ultracentrifugation and color dilution techniques , 1998 .
[239] M. Jägerstad,et al. Carcinogenic heterocyclic amines in model systems and cooked foods: a review on formation, occurrence and intake. , 1998, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[240] H. King,et al. Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.
[241] H. Hoeger,et al. Oral administration of methylglyoxal leads to kidney collagen accumulation in the mouse. , 1998, Life sciences.
[242] L. Kroh,et al. Formation of α-dicarbonyl fragments from mono- and disaccharides under caramelization and Maillard reaction conditions , 1998 .
[243] G. Wondrak,et al. Pentoses and Hexoses as Sources of New Melanoidin-like Maillard Polymers , 1998 .
[244] M. Nangaku,et al. Renal catabolism of advanced glycation end products: the fate of pentosidine. , 1998, Kidney international.
[245] A. Amos,et al. The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010 , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[246] H. Vlassara,et al. Standardizing the immunological measurement of advanced glycation endproducts using normal human serum. , 1997, Journal of immunological methods.
[247] A. Schmidt,et al. Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress* , 1997, The Journal of Biological Chemistry.
[248] R. Bucala,et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[249] J. Baynes,et al. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. , 1997, The Biochemical journal.
[250] T. J. Berg,et al. Increased Serum Levels of Advanced Glycation End Products (AGEs) in Children and Adolescents With IDDM , 1997, Diabetes Care.
[251] D. Sell. Ageing promotes the increase of early glycation Amadori product as assessed by ϵ-N-(2-furoylmethyl)-l-lysine (furosine) levels in rodent skin collagen The relationship to dietary restriction and glycoxidation , 1997, Mechanisms of Ageing and Development.
[252] H. Klostermeyer,et al. Detection and quantification of pentosidine in foods , 1997 .
[253] Alan W. Stitt,et al. Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[254] B. Caemmerer,et al. Investigation of the contribution of radicals to the mechanism of the early stage of the Maillard reaction , 1996 .
[255] J. V. Hunt,et al. Effect of flavones on glucose-induced changes in human serum albumen. , 1996, Biochemical Society transactions.
[256] R. Bucala,et al. Novel modifications of N a-boc-arginine and N a-CBZ-lysine by methylglyoxal , 1996 .
[257] T. Lyons,et al. The Advanced Glycation End Product, N-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions (*) , 1996, The Journal of Biological Chemistry.
[258] P. B. Chock,et al. Free Radicals Generated during the Glycation Reaction of Amino Acids by Methylglyoxal , 1995, The Journal of Biological Chemistry.
[259] V. Monnier,et al. Mechanism of Protein Modification by Glyoxal and Glycolaldehyde, Reactive Intermediates of the Maillard Reaction (*) , 1995, The Journal of Biological Chemistry.
[260] J. Baynes,et al. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. , 1995, Biochemistry.
[261] A. Schmidt,et al. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[262] H. Klostermeyer,et al. Detection and identification of a protein-bound imidazolone resulting from the reaction of arginine residues and methylglyoxal , 1994 .
[263] H. Erbersdobler,et al. Determination of Nε -carboxymethyllysine by a reversed-phase high-performance liquid chromatography method , 1994 .
[264] H. E. Berg,et al. Degradation of lactose during heating of milk. 1. Reaction pathways , 1994 .
[265] Y. Zou,et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. , 1993, The American journal of pathology.
[266] R. Bucala,et al. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[267] T. Shibamoto,et al. Gas chromatographic analysis of glyoxal and methylglyoxal formed from lipids and related compounds upon ultraviolet irradiation , 1993 .
[268] M. Brownlee,et al. Glycation Products and the Pathogenesis of Diabetic Complications , 1992, Diabetes Care.
[269] K. O. Elliston,et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. , 1992, The Journal of biological chemistry.
[270] R. Bucala,et al. Immunochemical detection of advanced glycosylation end products in vivo. , 1992, The Journal of biological chemistry.
[271] E. Friedman,et al. Advanced glycosylation end products in patients with diabetic nephropathy. , 1991, The New England journal of medicine.
[272] M. Suthanthiran,et al. Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins , 1991, The Journal of experimental medicine.
[273] H. Klostermeyer,et al. Evaluation of the extent of the early Maillard-reaction in milk products by direct measurement of the Amadori-product lactuloselysine , 1991, Zeitschrift fur Lebensmittel-Untersuchung und -Forschung.
[274] E. Schleicher,et al. New Aspects of the Maillard Reaction in Foods and in the Human Body , 1990 .
[275] R. Dean,et al. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. , 1988, The Biochemical journal.
[276] P. Finot,et al. Identification of N.epsilon.-carboxymethyllysine: a new Maillard reaction product in rat urine , 1987 .
[277] H. Vlassara,et al. Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors , 1986, The Journal of experimental medicine.
[278] M. Namiki,et al. Role of Sugar Fragmentation in an Early Stage Browning of Amino-carbonyl Reaction of Sugar with Amino Acid , 1986 .
[279] J. Baynes,et al. Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. , 1986, The Journal of biological chemistry.
[280] A. Cerami,et al. High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[281] Paul J Thornalley,et al. The autoxidation of glyceraldehyde and other simple monosaccharides , 1984, Experientia.
[282] M. Namiki,et al. A New Mechanism of the Maillard Reaction Involving Sugar Fragmentation and Free Radical Formation , 1983 .
[283] M. Namiki,et al. Formation of Two-Carbon Sugar Fragment at an Early Stage of the Browning Reaction of Sugar with Amine , 1980 .
[284] F. Hayase,et al. Formation of .EPSILON.-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-L-norleucine in the maillard reaction between D-glucose and L-lysine. , 1980 .
[285] J. Baynes,et al. Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum. , 1979, The Journal of biological chemistry.
[286] Y. Ohta,et al. Electron spin resonance spectral study on the structure of the novel free radical products formed by the reactions of sugars with amino acids or amines. , 1977, Journal of agricultural and food chemistry.
[287] H. Zahn,et al. Zum Vorkommen von Isopeptidbindungen in erhitztem Milcheiweiß , 1976 .
[288] M. Namiki,et al. Development of novel free radicals during the amino-carbonyl reaction of sugars with amino acids , 1975 .
[289] C. Chichester,et al. Nutritional consequences of the Maillard reaction. Amino acid availability from fructose-leucine and fructose-tryptophan in the rat. , 1973, The Journal of nutrition.
[290] O. Blumenfeld,et al. Studies of an unusual hemoglobin in patients with diabetes mellitus. , 1969, Biochemical and biophysical research communications.
[291] E. A. Day,et al. Further observations on the dicarbonyl compounds formed via autoxidation of methyl linoleate , 1965, Journal of the American Oil Chemists' Society.
[292] J. Hodge. Dehydrated Foods, Chemistry of Browning Reactions in Model Systems , 1953 .
[293] I. Seiquer,et al. Increased Maillard reaction products intake reduces phosphorus digestibility in male adolescents. , 2011, Nutrition.
[294] V. Yaylayan,et al. The Maillard reaction and food quality deterioration. , 2010 .
[295] D. Noto,et al. A novel component of the metabolic syndrome: the oxidative stress. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[296] G. Striker,et al. AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation. , 2008, American journal of physiology. Cell physiology.
[297] Nessar Ahmed,et al. Advanced glycation endproducts--role in pathology of diabetic complications. , 2005, Diabetes research and clinical practice.
[298] H. Klostermeyer,et al. Protein-Bound Maillard Compounds in Foods: Analytical and Technological Aspects , 2005 .
[299] R. Bucala,et al. Association between acute-phase reactants and advanced glycation end products in type 2 diabetes. , 2004, Diabetes care.
[300] T. Opitz,et al. Studies on the occurrence and formation of 1,2-dicarbonyls in honey , 2004 .
[301] Hiroshi Yamamoto,et al. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes. , 2003, Journal of diabetes and its complications.
[302] Grace S. L. Lee,et al. End-stage renal disease in the Asian-Pacific region. , 2003, Seminars in nephrology.
[303] R. Schinzel,et al. Advanced glycation end products and nutrition. , 2002, Physiological research.
[304] R. Nagaraj,et al. N(delta)-(5-hydroxy-4,6-dimethylpyrimidine-2-yl)-l-ornithine, a novel methylglyoxal-arginine modification in beer. , 2001, Journal of agricultural and food chemistry.
[305] Y. Aso,et al. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes , 2000, Acta Diabetologica.
[306] Paul J Thornalley. THE CLINICAL SIGNIFICANCE OF GLYCATION , 1999 .
[307] J. Baynes,et al. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.
[308] S. Vasdev,et al. Aldehyde induced hypertension in rats: prevention by N-acetyl cysteine. , 1998, Artery.
[309] P. Riederer,et al. Determination of Advanced Glycation End Products in Serum by Fluorescence Spectroscopy and Competitive ELISA , 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[310] T. Henle,et al. Synthesis of pyrraline reference material , 1996, Zeitschrift fur Lebensmittel-Untersuchung und -Forschung.
[311] M. Brownlee,et al. Advanced protein glycosylation in diabetes and aging. , 1995, Annual review of medicine.
[312] M. Friedman,et al. Dietary impact of food processing. , 1992, Annual review of nutrition.
[313] R. Bucala,et al. Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. , 1992, Advances in pharmacology.
[314] P. Morrissey,et al. Nutritional and toxicological aspects of the Maillard browning reaction in foods. , 1989, Critical reviews in food science and nutrition.
[315] J. Baynes,et al. [8] Nonenzymatic glucosylation of lysine residues in albumin , 1984 .
[316] P. Finot,et al. Metabolic transit of early and advanced Maillard products. , 1981, Progress in food & nutrition science.
[317] H. Kato. Estimation of melanoidin structure by pyrolysis and oxidation. , 1981 .
[318] S. Kusumoto,et al. Nε-(carboxymethyl)-l-lysine in the acid hydrolysate of Sagittaria pygmaea , 1979 .
[319] R. Pethig,et al. Electronic properties of the casein-methylglyoxal complex. , 1977, Proceedings of the National Academy of Sciences of the United States of America.